REDNVIA Co., Ltd.

1 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) (NCT05143177)	REDNVIA Co., Ltd.	2022-06-27

Every clearance here is in the API, with alerts when new ones post.